{
    "clinical_study": {
        "@rank": "126220", 
        "arm_group": [
            {
                "arm_group_label": "no therapy", 
                "arm_group_type": "No Intervention"
            }, 
            {
                "arm_group_label": "antimicrobial treatment according to in-vitro susceptibility", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators hypothesize that antibiotic therapy for asymptomatic bacteriuria in renal\n      transplant patients does not have impact on the development of symptomatic urinary tract\n      infection (UTI) or progression of renal impairment in patients during the first year after\n      transplantation."
        }, 
        "brief_title": "The Impact of Antimicrobial Treatment for Asymptomatic Bacteriuria in Renal Transplant Patients", 
        "condition": [
            "Urinary Tract Infection", 
            "Bacteriuria", 
            "Renal Transplantation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bacteriuria", 
                "Urinary Tract Infections"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who are \u22651 month and \u2264 12 months after renal transplantation.\n\n          -  Positive urine culture defined as \u2265 105 colony forming units (CFU) per milliliter of\n             a known single pathogen.\n\n        Exclusion Criteria:\n\n          -  Any one of the following signs and symptoms: fever, abdominal pain, dysuria,\n             frequency, urgency, flank pain, costovertebral-angel tenderness or tenderness over\n             the transplanted kidney\n\n          -  Active infections in another site\n\n          -  Leucocytosis (WBC >18.000K/micl) or leucopenia (WBC < 3.000 K/micl)\n\n          -  Elevation of serum creatinine of more than 15% of its baseline level\n\n          -  Obstructive or other urological complications following transplantation as known\n             foreign device (stent/double-J-Cath, any catheter) in the urinary tract system, known\n             obstruction of the transplanted kidney, indwelling or intermittent catheterization\n\n          -  Pregnant or lactating women.\n\n          -  Candidates to invasive urologic procedures.\n\n          -  Inability to return for regular follow up.\n\n          -  Previous enrollment in this study.\n\n          -  Patients who incapable of giving informed consent."
            }, 
            "gender": "Both", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "March 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02113774", 
            "org_study_id": "7687"
        }, 
        "intervention": {
            "arm_group_label": "antimicrobial treatment according to in-vitro susceptibility", 
            "intervention_name": "antimicrobial treatment according to in-vitro susceptibility", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Anti-Infective Agents"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 14, 2014", 
        "other_outcome": {
            "measure": "graft loss", 
            "time_frame": "1 year"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "development of symptomatic urinary tract infection", 
            "time_frame": "30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02113774"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rabin Medical Center", 
            "investigator_full_name": "Ruth Rahamimov", 
            "investigator_title": "head of transplant investigator service", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "25% reduction in estimated glomerular filtration rate (eGFR)", 
            "time_frame": "1 year"
        }, 
        "source": "Rabin Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rabin Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}